Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Stefanos Bonovas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., El-Hussuna, A., Ellul, P., Frei-Lanter, C., Furfaro, F., Gingert, C. & 26 others, Gionchetti, P., Gomollon, F., González-Lorenzo, M., Gordon, H., Hlavaty, T., Juillerat, P., Katsanos, K., Kopylov, U., Krustins, E., Lytras, T., Maaser, C., Magro, F., Marshall, J. K., Myrelid, P., Pellino, G., Rosa, I., Sabino, J., Savarino, E., Spinelli, A., Stassen, L., Uzzan, M., Vavricka, S., Verstockt, B., Warusavitarne, J., Zmora, O. & Fiorino, G., Jan 1 2020, In : Journal of Crohn's & colitis. 14, 1, p. 4-22 19 p.

Research output: Contribution to journalArticle

  • Inflammatory bowel disease: estimates from the global burden of disease 2017 study

    Piovani, D., Danese, S., Peyrin-Biroulet, L. & Bonovas, S., Jan 2020, In : Alimentary Pharmacology and Therapeutics. 51, 2, p. 261-270 10 p.

    Research output: Contribution to journalArticle

  • Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

    D'Amico, F., Pouillon, L., Argollo, M., Hart, A., Fiorino, G., Vegni, E., Radice, S., Gilardi, D., Fazio, M., Leone, S., Bonovas, S., Magro, F., Danese, S. & Peyrin-Biroulet, L., Feb 2020, In : Digestive and Liver Disease. 52, 2, p. 138-142 5 p.

    Research output: Contribution to journalReview article

  • A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

    Danese, S., Hart, A., Dignass, A., Fiorino, G., Louis, E., Bonovas, S., D'Haens, G., Dotan, I., Rogler, G., Paridaens, K. & Peyrin-Biroulet, L., Nov 2019, In : United Eur. Gastroenterol. J.. 7, 9, p. 1171-1182 12 p.

    Research output: Contribution to journalArticle